MedTrace Logo

Pulse Oximeter Screening in Congenital Heart Disease

NCT02731248 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2016-04-07

No results posted yet for this study

Summary

Pulse oximetry screening of newborn infants increases early detection of critical congenital heart disease and minimises the risk of circulatory collapse before surgery. This study provides an update on the implementation of pulse oximetry screening in Turkey

Conditions

  • Congenital Heart Disease

Interventions

OTHER

Prospective screening study

Prospective screening study in newborns

Sponsors & Collaborators

  • Dr. Sami Ulus Children's Hospital

    lead OTHER

Principal Investigators

  • Dilek Dilli, Assoc Prof · DR sami Ulus Training and Research Hospital

Eligibility

Min Age
1 Day
Max Age
5 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-04-30
Completion
2017-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02731248 on ClinicalTrials.gov